Shukra Pharmaceuticals Ltd
Who owns it
Promoter holding has held steady at 51.15% across all 8 quarters on record — no dilution, no exit.
None of the promoter’s holding is pledged, in any quarter of the series.
Loading the quarter figures…
Ownership shown is promoter, public and pledge.
How it trades
Loading trading data…
Splits, bonuses and rights
- 21 Mar 2025
Each share became 10. The price divides by the same factor, so a chart falling about 90% that day is that arithmetic, not a loss.
Listed ahead of its ex-date — scheduled, not yet gone ex. Ex-dates that have already passed are shown separately below.
Shown from Aug 2024, as far back as we can certify the record complete; earlier actions are not listed. Scheduled dividends are listed ahead of their ex-date, and past dividend ex-dates from the same window when on record — a stock with none shown either paid none in that window or predates our records; never read the absence as Shukra Pharmaceuticals Ltd having paid none.
Fundamentals and valuation — we hold neither. The FII / DII / government split of public holding — not carried yet.
This page reports what Shukra Pharmaceuticals Ltd disclosed to the exchange and how its shares have traded. It states no view on the stock and is not advice. Every figure is dated to the filing it came from; absence is stated, never shown as zero.